Effectiveness of Tocotrienol-Rich Fraction in Older Adults: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial
JMIR Research Protocols · 2025
DOI: 10.2196/73039 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Nor Amira Nabila Amir Razak und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Tocotrienols, Dietary Supplements. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Tocotrienol, a naturally occurring form of vitamin E, has been extensively studied for its potent antioxidant, anti-inflammatory, and immune-stimulating properties. However, the clinical impact of tocotrienol supplementation on older adults’ overall health and well-being remains relatively unexplored. This research aims to investigate the efficacy of tocotrienol-rich fraction (TRF) on various health parameters associated with general well-being in individuals aged between 50 years and 75 years.
Objective
It is hypothesized that TRF supplementation may exhibit positive outcomes on blood biochemistry and several physiological aspects, including lowered levels of oxidative stress and inflammation biomarkers; improvement in vascular age; and enhancement of skin condition, bone mineral density, and cognitive function.
Methods
This randomized, double-blind, placebo-controlled trial was designed to investigate the effectiveness of TRF supplementation on overall health in healthy older adults. The study aims to assess the impact of a daily dosage of 200 mg of TRF over a period of 6 months. A total of 220 participants is enrolled in the study, with one-half receiving the placebo and the other one-half receiving TRF supplementation. The study comprises 3 time points: baseline, 3 months, and 6 months. At each time point, various measurements are taken to evaluate different aspects of health. The primary outcome measurements include blood biochemistry assessments, such as liver function tests, renal profile, lipid profile, and full blood count. Oxidative stress markers, including malondialdehyde, advanced glycation end products, protein carbonyl, and isoprostane, are also evaluated. Immune response markers such as interleukin-6 and tumor necrosis factor-α are assessed. Satiety regulation is examined through measurements of leptin and ghrelin. Body composition and skin health parameters, including wrinkling, pigmentation, elasticity, hydration, and sebum secretion, are evaluated. Additionally, arterial stiffness is assessed using arteriography at baseline and 6 months. For secondary outcome measures, bone mineral density is measured using dual x-ray absorptiometry, and cognitive function is assessed using the Montreal Cognitive Assessment, Rey Auditory Verbal Learning Test, and digital span test. Both bone mineral density and cognitive function are also measured at baseline and 6 months.
Results
The study is progressing as planned, with 209 participants recruited as of April 2025. The research was funded in 2019, and data collection started in December 2020. Preliminary data analysis has been completed for the first 120 participants, and final results are expected upon completion of data collection and unblinding in 2026.
Conclusions
By comprehensively evaluating these health aspects, this study seeks to provide valuable insights into the potential benefits of tocotrienol supplementation for promoting the overall health and well-being of the aging population. Trial Registration National Medical Research Register (NMRR) NMRR-19-2972-51179; https://tinyurl.com/yy9yueer International Registered Report Identifier (IRRID) DERR1-10.2196/73039
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
- Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
- Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
- Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
- Research and Development Department, Davos Life Science, Singapore, Singapore.
- Research and Development Department, KL-Kepong Oleomas, Selangor, Malaysia.
ORCID-Profile: Nor Amira Nabila Amir Razak, Jo Aan Goon, Wan Zurinah Wan Ngah, Suzana Makpol, Mohd Hanafi Ahmad Damanhuri, Nor Faeizah Ibrahim, Nur Fathiah Abdul Sani, Nuraqila Mohd Murshid, Anis Faqihah Mohd Azizan, Kok Yong Chin, Amilia Aminuddin, Mohd Heikal Mohd Yunus, Munirah Md Mansor, Juvenia Rui En Neo, Wei Ney Yap, Hsieu Yen Loong, Yee Wei Ung
Zitieren
APA
Amir Razak, N. A. N., Goon, J. A., Wan Ngah, W. Z., Makpol, S., Ahmad Damanhuri, M. H., Ibrahim, N. F., Abdul Sani, N. F., Mohd Murshid, N., Mohd Azizan, A. F., Chin, K. Y., Aminuddin, A., Mohd Yunus, M. H., Md Mansor, M., Neo, J. R. E., Yap, W. N., Loong, H. Y., & Ung, Y. W. (2025). Effectiveness of Tocotrienol-Rich Fraction in Older Adults: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/73039
Vancouver
Amir Razak NAN, Goon JA, Wan Ngah WZ, Makpol S, Ahmad Damanhuri MH, Ibrahim NF, et al. Effectiveness of Tocotrienol-Rich Fraction in Older Adults: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/73039
BibTeX
@article{AmirRazak2025,
author = {Amir Razak, Nor Amira Nabila and Goon, Jo Aan and Wan Ngah, Wan Zurinah and Makpol, Suzana and Ahmad Damanhuri, Mohd Hanafi and Ibrahim, Nor Faeizah and Abdul Sani, Nur Fathiah and Mohd Murshid, Nuraqila and Mohd Azizan, Anis Faqihah and Chin, Kok Yong and Aminuddin, Amilia and Mohd Yunus, Mohd Heikal and Md Mansor, Munirah and Neo, Juvenia Rui En and Yap, Wei Ney and Loong, Hsieu Yen and Ung, Yee Wei},
title = {Effectiveness of Tocotrienol-Rich Fraction in Older Adults: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/73039}
}
EUVIMED